Effect of NBI-921355 on corticospinal excitability in healthy participants
NBI-921355-1785
Phase 1 other active
Quick answer
Effect of NBI-921355 on corticospinal excitability in healthy participants for Epilepsy is a Phase 1 program (other) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEUROCRINE BIOSCIENCES INC
- Indication
- Epilepsy
- Phase
- Phase 1
- Modality
- other
- Status
- active